Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00312260Phase 3Completed
Phase 3, randomised, double-blind trial of gabapentin in neuropathic pain, sponsored by SickKids. Primary endpoint: Change in child's pain intensity score at 6 weeks. Started Apr 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00312260.